Earnings
Home›Earnings›Analyst Ratings›Danaher and Intuitive Surgical diverge as growth stori…
Danaher and Intuitive Surgical diverge as growth stories split
Danaher pointed to mid-teens bioprocessing order growth and more than $100 million of revenue shifting into next year, while Intuitive Surgical said about 85% of revenue came from recurring sources.
Healthcare investors are weighing two different growth paths as Danaher and Intuitive Surgical chart contrasting momentum, with Danaher tied to a recovery in life sciences spending and Intuitive Surgical continuing to expand recurring revenue from robotic surgery, according to Yahoo Finance.
Yahoo Finance reports that Danaher’s Life Sciences segment delivered its strongest performance in several years, with bioprocessing orders growing in the mid-teens during the quarter. The company also said a little over $100 million of revenue moved into next year, mainly from the second and third quarters, suggesting demand was delayed rather than canceled.
By comparison, Intuitive Surgical’s model is built on recurring revenue tied to its installed base, with Yahoo Finance citing that about 85% of total revenue came from recurring sources during the quarter. The outlet also notes that adoption of the company’s newest da Vinci 5 platform is accelerating, reflecting continued hospital investment despite macroeconomic uncertainty.
Yahoo Finance frames the core debate for long-term investors as whether Danaher’s cyclical recovery or Intuitive Surgical’s structural, recurring-growth profile offers the better opportunity.